IP Library Granted Patent US 8,055,108
Granted Patent B2
US 8,055,108 · App. 12/366,323 · Granted Nov 8, 2011

Broadband or mid-infrared fiber light sources

Assignee: Cheetah Omni, L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,055,108
App. No.
12/366,323
Granted
Nov 8, 2011
Kind
B2
Abstract

A broadband light source includes one or more laser diodes that are capable of generating a pump signal having a wavelength shorter than 2.5 microns, a pulse width of at least 100 picoseconds and a pump optical spectral width. The light source also includes one or more optical amplifiers that are coupled to the pump signal and are capable of amplifying the pump signal to a peak power of at least 500 W. The light source further includes a first fiber that is coupled to the one or more optical amplifiers. The first fiber including an anomalous group-velocity dispersion regime and a modulational instability mechanism that operates to modulate the pump signal. In one particular embodiment, the pump signal wavelength resides in the anomalous group-velocity dispersion regime of the first fiber and where different intensities in the pump signal can cause relative motion between different parts of the modulated pump signal produced through modulational instability in the first fiber. The light source also including a nonlinear element that is coupled to the first fiber that is capable of broadening the pump optical spectral width to at least 100 nm through a nonlinear effect in the nonlinear element.

Claims (17)

1. An optical system for use in a medical procedure, the system comprising:

one or more laser diodes capable of generating one or more optical signals;

a gain fiber coupled to the one of more laser diodes, the gain fiber receiving the one or more optical signals and generating a corresponding pump signal having at least one wavelength;

a wavelength shifter coupled to the gain fiber, the wavelength shifter adapted to wavelength shift the at least one wavelength of the pump signal to a shifted pump wavelength based at least in part on a Raman wavelength shifting mechanism, wherein the shifted pump wavelength is in a wavelength range between approximately 1700 nm and 1900 nm; and

a lens system adapted to receive and deliver at least a portion of the wavelength-shifted pump signal to unwanted parts of tissue, to substantially damage the unwanted parts without significantly damaging surrounding tissue or tissue above the unwanted parts, wherein the shifted pump wavelength is selected to obtain a desired penetration depth and to substantially minimize water absorption, wherein the wavelength-shifted pump signal has a pulse width greater than approximately 100 picoseconds, wherein a time averaged output power of the wavelength-shifted pump signal is 20 mW or more, and wherein an intensity of the wavelength-shifted pump signal delivered by the lens system is less than approximately 50 MW/cm 2 .

2. The optical system of claim 1 , wherein the wavelength shifter comprises a Raman oscillator that comprises an optical fiber and a plurality of optical gratings.

3. The optical system of claim 1 , wherein the gain fiber further comprises one or more optical gratings.

4. The optical system of claim 1 , wherein the gain fiber is a cladding pumped fiber co-doped with erbium and ytterbium.

5. The optical system of claim 1 , wherein the shifted pump wavelength is in a wavelength range between approximately 1710 nm and 1740 nm.

6. The optical system of claim 1 , wherein at least the portion of the wavelength-shifted pump signal has a beam quality factor of M 2 less than approximately 1.4 and wherein the wavelength-shifted pump signal has a repetition rate between continuous wave and several Megahertz.

7. The optical system of claim 1 , wherein the unwanted parts of tissue comprise protein, amino acids, or amide groups.

8. The optical system of claim 1 , wherein the shifted pump wavelength comprises an optical wavelength where an optical absorption in the unwanted parts of tissue exceeds an optical absorption of water.

9. The optical system of claim 1 , wherein the gain fiber coupled to the one or more laser diodes is a cladding pumped fiber laser and wherein the wavelength shifter is a cascaded Raman wavelength shifter comprising an optical fiber and a plurality of optical gratings.

10. The optical system of claim 9 , wherein the cascaded Raman wavelength shifter is adapted to wavelength shift the at least one wavelength of the pump signal to the shifted pump signal through at least two Raman orders.

11. The optical system of claim 1 , wherein the medical procedure is a minimally invasive procedure.

12. The optical system of claim 1 , wherein the pulse width of the wavelength-shifted pump signal is less than 100 nanoseconds.

13. The optical system of claim 1 , wherein the unwanted parts of tissue have at least in part nerve agents that disrupt one or more mechanisms by which nerves transfer messages to organs.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2023
From: OMNI MEDSCI, INC.
To: OMNI CONTINUUM, LLC
Reel/Frame 063126/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 10, 2014
From: CHEETAH OMNI LLC
To: OMNI MEDSCI, INC.
Reel/Frame 031937/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2010
From: OMNI SCIENCES, INC.
To: CHEETAH OMNI, L.L.C.
Reel/Frame 024394/0614 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 5, 2009
From: ISLAM, MOHAMMED N.
To: OMNI SICENCES, INC.
Reel/Frame 022216/0415 →
Continuity (3)
Continuation 11599950 · Nov 15, 2006
Provisional Application 60738389 · Nov 18, 2005
Related Publication 20090204110A1 · Aug 13, 2009